Related Experiment Video

Updated: Dec 18, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Flight of the COVID-19 patient: experience with a Wuhan evacuee: a case report

Sandeep Segar1,2, Daniel Bouland1,2, Francesca Torriani2,3

  • 1Division of Hospital Medicine, University of California San Diego Health, 200 West Arbor Drive, MC 8485, San Diego, CA, 92103, USA.

Journal of Medical Case Reports
|June 13, 2020
PubMed

Insights

A case study of a 51-year-old woman with coronavirus disease 2019 (COVID-19) details her recovery after treatment with remdesivir. The patient experienced typical symptoms and was successfully discharged after hospitalization.

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic.
  • The World Health Organization declared COVID-19 a global pandemic in March 2020.

Observation:

  • A 51-year-old Chinese woman diagnosed with COVID-19 upon arrival at a California quarantine facility.
  • Clinical presentation included high fevers, night sweats, cough, leukopenia, lymphopenia, thrombocytopenia, and transaminitis.
  • Hypoxia and chest imaging findings necessitated treatment with remdesivir.

Findings:

  • The patient's symptoms evolved, requiring medical intervention.
  • Remdesivir was administered as an investigational antiviral treatment.
  • The patient recovered and was discharged after two weeks.

Implications:

  • This case provides insights into the clinical management of COVID-19.
  • It highlights challenges in determining non-infectivity for a novel disease.
  • Understanding patient recovery pathways is crucial for pandemic response.
Abstract

Keywords:
2019 novel coronavirusCOVID-19QuarantineRemdesivirSARS-CoV-2Severe acute respiratory syndrome coronavirus 2

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

767
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
688
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
893
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
637
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
355
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
625
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
491